Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hepatitis C and renal failure.

R L Carithers1

  • 1Department of Medicine, University of Washington Medical Center, Seattle 98195, USA.

The American Journal of Medicine
|February 1, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical trial: interferon alpha-2b continuous long-term therapy vs. repeated 24-week cycles for re-treating chronic hepatitis C.

Alimentary pharmacology & therapeutics·2007
Same author

Cholestasis and alcoholic liver disease.

Clinics in liver disease·2001
Same author

Hepatitis C in clinical practice.

Journal of internal medicine·2001
Same author

Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy.

Journal of virology·2000
Same author

Diagnostic testing for hepatitis C.

Seminars in liver disease·2000
Same author

The protein kinase-interacting domain in the hepatitis C virus envelope glycoprotein-2 gene is highly conserved in genotype 1-infected patients treated with interferon.

The Journal of infectious diseases·2000
Same journal

GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

The American journal of medicine·2026
Same journal

Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

The American journal of medicine·2026
Same journal

Cave Canem - Beware of the Dog.

The American journal of medicine·2026
Same journal

Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

The American journal of medicine·2026
Same journal

Mesenteric Panniculitis.

The American journal of medicine·2026
Same journal

Hypercalcemia and hyperferritinemia in a patient with Graves' disease disease.

The American journal of medicine·2026
See all related articles

Chronic hepatitis C virus (HCV) infection is prevalent in patients with chronic renal failure, leading to serious health issues. Early recognition is crucial for managing HCV patients undergoing renal replacement therapy.

Area of Science:

  • Nephrology
  • Hepatology
  • Infectious Diseases

Background:

  • Chronic hepatitis C virus (HCV) infection is a significant health concern in patients with chronic renal failure.
  • HCV infection contributes to substantial morbidity and mortality in this population.
  • Liver failure due to HCV is a leading cause of death in renal transplant recipients.

Purpose of the Study:

  • To highlight the impact of HCV infection on patients with chronic renal failure.
  • To emphasize the association between HCV and kidney diseases like glomerulonephritis and nephrotic syndrome.
  • To underscore the importance of recognizing and managing HCV in renal patients.

Main Methods:

  • This abstract is based on a review of existing literature and clinical observations.

Related Experiment Videos

  • No new experimental data were generated for this summary.
  • The focus is on summarizing established knowledge regarding HCV in renal disease.

    • Main Results:

    • HCV infection is common in patients with chronic renal failure.
    • HCV can lead to severe outcomes, including liver failure, particularly post-transplant.
    • HCV is implicated as a cause of glomerulonephritis and nephrotic syndrome.

    Conclusions:

    • HCV infection poses a significant threat to patients with chronic renal failure.
    • The recognition of HCV-related kidney diseases is critical for patient management.
    • Optimizing the care of these patients requires a comprehensive approach to HCV infection.